Triana Biomedicines

United States
Altona, Illinois, United States, 02421

Company profile

Triana Biomedicines company profile

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Triana’s drug discovery engine is powered by high-resolution structural insights, state-of-the-art in silico tools, and bespoke chemical libraries. The research team has validated the best-in-class platform and initiated multiple programs across different disease areas.

Business identity

Contact email
[email protected]
Phone number
(781) 317-4414
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2019-01-01, Year

Headquarters

Postal code
02421
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
5
Total equity funding
$280.8M
Last funding
Series B / $120M / 2025-12-03
Last equity funding
Series B / $120M
Investors
12
Lead investors
5
Founders
3
Articles
27

Founders and investors

Founders

Jesse ChenMilind DeshpandeSimon Read

Lead investors

Ascenta CapitalAtlas VentureBessemer Venture PartnersLightspeed Venture PartnersRA Capital Management

Investors

Atlas VentureBessemer Venture PartnersInvusLightspeed Venture PartnersRA Capital Management